NRX Pharmaceuticals, Inc. (NRXP)

CIK 1719406 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for NRX Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 2026DEFA14A0001437749-26-035308
Nov 5, 2026DEF 14A0001437749-26-035303
Nov 4, 202640001437749-26-035010
Nov 4, 202640001437749-26-035009
Nov 2, 20268-K0001437749-26-034284
Oct 16, 20268-K0001437749-26-032828
Oct 5, 20268-K0001437749-26-032042
Sep 16, 20268-K0001437749-26-030492
Sep 14, 20268-K0001437749-26-030228
Aug 17, 20268-K0001437749-26-028111
Aug 14, 202610-Q0001437749-26-028027
Aug 7, 20268-K0001437749-26-026428
Jul 22, 20268-K0001437749-26-024037
Jun 4, 20268-K0001437749-26-019576
Jun 3, 2026424B50001437749-26-019368
Jun 2, 20268-K0001437749-26-019196
Jun 2, 2026424B50001437749-26-019194
May 22, 202625-NSE0001354457-26-000493
May 15, 2026SCHEDULE 13G/A0001193125-26-225997
May 15, 202610-Q0001437749-26-017397
Mar 24, 20268-K0001437749-26-009611
Mar 23, 202610-K0001437749-26-009418
Feb 24, 2026DEFA14A0001437749-26-005362
Feb 23, 2026ARS0001437749-26-005124
Feb 23, 2026DEF 14A0001437749-26-005119